Cornelia Mauch

3PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 19, 2025
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma.

Reinhard Dummer, Shahneen Sandhu, Wilson H Miller

|Jan 19, 2017
The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma.

Melina Mescher, Peter Jeong, Sina K Knapp

Pageof 1